Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis

检查抗精神病药物共同决策干预的有效性,以提高早期精神病患者的治疗参与度

基本信息

项目摘要

Project Summary Shared decision making (SDM) is a process that involves open discussion between patient and clinician with the goal of improving treatment engagement and quality of care. Cumulative research as well as the recent edition of the American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia recognize the need for SDM when making decisions about antipsychotic medication (APM) and identify the lack of SDM in psychiatric care as a factor contributing to inconsistent APM use. The high rates of premature treatment discontinuation and inconsistent use of APM among individuals with first episode psychosis (FEP), who are at high risk for relapse and clinical deterioration, make SDM a public health priority. SDM is considered by the NIMH to be a framework within a coordinated specialty care (CSC) treatment model for FEP to improve care and engagement. Yet, to date, there is a gap between recommendations for using SDM and its actual use in psychiatric visits. In addition, evidence-based SDM interventions for APM decisions in psychiatry, especially in early psychosis care, are lacking, and the mechanism of SDM is yet to be defined. To fill these gaps, our project provides the first evidence-based SDM intervention for making decisions about APM within a FEP CSC treatment model. We will further develop our existing SDM intervention for psychosis, the Antipsychotic Medication Decision Aid (APM-DA), which was developed according to the highest International Patient Decision Aid Standards (IPDAS) and quality criteria. We hypothesize that the use of the APM-DA intervention in psychiatric visits focused on APM management for FEP will improve SDM targets (trust in the clinician, active participation in APM decisions, knowledge of APM and FEP), which will produce improved SDM proximal (level of SDM, program engagement, consistent use of APM) and distal outcomes (positive recovery attitudes, less severe symptoms over time, fewer ED visits and hospitalizations). This pilot effectiveness trial has two aims. In Aim 1, we will develop a delivery protocol and training materials for using the APM-DA in psychiatric visits in a large CSC program, OnTrackNY. Step 1 involves a qualitative formative study to develop the protocol and training materials (25 interviews), and Step 2 involves an open pilot trial of the protocol and training materials for final refinement with 20 patient participants. In Aim 2, we will conduct a cluster RCT at 6 CSC clinics with 120 patient participants (60 in each arm) to test potential mechanism/targets and impact of the APM-DA intervention compared with treatment as usual. Successful completion will result in an evidence-based SDM intervention that addresses an NIMH strategic goal to improve the quality of APM management for individuals with psychosis. Upon completion, a larger APM-DA clinical trial will be conducted via a subsequent R01.
项目摘要 共享决策(SDM)是一个过程,涉及患者和临床医生之间的公开讨论, 提高治疗参与度和护理质量的目标。累积的研究以及最近的 美国精神病学协会治疗精神分裂症患者的实践指南 精神分裂症患者在决定服用抗精神病药物(APM)时认识到需要SDM, 确定精神病护理中缺乏SDM是导致APM使用不一致的一个因素。率高 在首次发作的个体中提前停止治疗和不一致地使用APM 精神病(FEP)复发和临床恶化的高风险人群使SDM成为公共卫生优先事项。 SDM被NIMH认为是协调专科护理(CSC)治疗模式的框架 以改善护理和参与。然而,到目前为止,使用建议之间存在差距 SDM及其在精神科就诊中的实际使用。此外,可持续发展机制对APM决策的循证干预 在精神病学中,特别是在早期精神病护理中,缺乏,并且SDM的机制尚未被定义。 为了填补这些空白,我们的项目提供了第一个以证据为基础的SDM干预, FEP CSC治疗模型中的APM。我们将进一步发展我们现有的SDM干预精神病, 抗精神病药物决策援助(APM-DA),这是根据最高的开发 国际患者决策辅助标准(IPDAS)和质量标准。我们假设使用 在精神科就诊中进行APM-DA干预,重点关注FEP的APM管理,将改善SDM目标 (信任临床医生,积极参与APM决策,了解APM和FEP),这将产生 改善SDM近端(SDM水平、项目参与、APM的一致使用)和远端结局 (积极的恢复态度,随着时间的推移症状不太严重,艾德就诊和住院次数减少)。这一试点 有效性试验有两个目的。在目标1中,我们将制定一个交付协议和培训材料, APM-DA在一个大型CSC项目OnTrackNY中的精神病访问中。第一步是一个定性的形成 第二步是进行一项公开的试点试验, 方案和培训材料,以供20名患者参与者最终完善。在目标2中,我们将进行 在6家CSC诊所进行随机对照试验,120名患者参与(每组60名),以测试潜在机制/靶点 与常规治疗相比,APM-DA干预的影响。成功完成将导致 基于证据的SDM干预,解决NIMH的战略目标,以提高APM的质量 精神病患者的管理。完成后,将进行更大规模的APM-DA临床试验 通过后续的R 01。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA B. DIXON其他文献

LISA B. DIXON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA B. DIXON', 18)}}的其他基金

Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
检查抗精神病药物共同决策干预的有效性,以提高早期精神病患者的治疗参与度
  • 批准号:
    10670896
  • 财政年份:
    2022
  • 资助金额:
    $ 26.47万
  • 项目类别:
Optimizing Disability Benefit Decisions and Outcomes in First Episode Psychosis
优化首发精神病中的残疾福利决策和结果
  • 批准号:
    10521916
  • 财政年份:
    2022
  • 资助金额:
    $ 26.47万
  • 项目类别:
Adapting Coordinated Specialty Care in the Post COVID-19 Era
在后 COVID-19 时代调整协调专业护理
  • 批准号:
    10193474
  • 财政年份:
    2019
  • 资助金额:
    $ 26.47万
  • 项目类别:
Zero Suicide Implementation and Evaluation in Outpatient Mental Health Clinics
门诊心理健康诊所零自杀实施与评估
  • 批准号:
    10572128
  • 财政年份:
    2016
  • 资助金额:
    $ 26.47万
  • 项目类别:
Improving Life Trajectories for Youth with Early Psychosis
改善早期精神病青少年的生活轨迹
  • 批准号:
    8916281
  • 财政年份:
    2014
  • 资助金额:
    $ 26.47万
  • 项目类别:
OnTrack>An Online Role-Playing Game
OnTrack>在线角色扮演游戏
  • 批准号:
    9253043
  • 财政年份:
    2014
  • 资助金额:
    $ 26.47万
  • 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
  • 批准号:
    8195952
  • 财政年份:
    2009
  • 资助金额:
    $ 26.47万
  • 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
  • 批准号:
    8392115
  • 财政年份:
    2009
  • 资助金额:
    $ 26.47万
  • 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
  • 批准号:
    7916627
  • 财政年份:
    2009
  • 资助金额:
    $ 26.47万
  • 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
  • 批准号:
    7786750
  • 财政年份:
    2009
  • 资助金额:
    $ 26.47万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 26.47万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 26.47万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 26.47万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 26.47万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 26.47万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 26.47万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 26.47万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 26.47万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 26.47万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 26.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了